Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You say about the new "10% completed*" website
Ask Janice.
I did
That's the main page we saw yesterday, but you can't click on any section to navigate for more info, and a lot of parts are missing (company info, products, etc)
Here is what a well designed and functioning website looks like
https://www.illumina.com/
What do you mean. It's the same as yesterday, under construction.
But lower than in February 2019. Lower is good.
Outstanding Shares
1,127,115,244
02/28/2019
Restricted
83,326,440
02/28/2019
Unrestricted
1,043,788,804
02/28/2019
Thanks for the SS update
It's the same as it was yesterday. A very rough prototype. NOT ANYWHERE NEAR DONE.
I think it's the same technology. Ovadx blood sample is obtained from a finger prick and put on a blood card.
Yes. The colon cancer mention is new. The others were in the old website for years.
A half-ass website propels the pps up 40%.
imagine what a professionally finished product could do.
Yes it's hilarious. It's a link to the generic template that they are using to build their website. Way to go before they have a finished product. Real customers that visit Arayit's website to get info about their products must be scratching their heads and moving on to a different supplier.
Agreed. It's a shame that they put this not-finished website into production. What half way reasonable company does that?
I don't know what they tried to accomplished by rolling out this mess.
I have no reason to believe that they have not aced the proficiency three years in a row. 2017-9
But Nielson is the only one that has filed form 13 and form 4 as required by the SEC for shareholders who own 10% or more of the O/S
No, pinnertest issues is that IgG tests in general, no matter who runs them are not recommended by doctors
But the allergy test has aced the proficiency tests something that Theranos never did.
Taub filed for reconsideration of the judge's prior decision denying him the summary judgement motion for the claim of breach of contract.
If the judge sustains his prior decision, then Taub has to either settle or go to trial.
That 90 day period is under 12-g rule to terminate registration. Rene checked only Rule 12h-3 box on the form 15 to suspend reporting, not the 12-g rule.
Under Rule 12h-3 a company can suspend reporting intermediately if the rule's requirements are met.
How does an issuer terminate its reporting obligation
arising because the issuer has a class of securities
registered, or deemed registered, under Section 12(g)?
An issuer seeking to terminate its registration under
Section 12(g) must file a Form 15. Form 15 provides a
certification and notice of termination of registration
under Rule 12(g), which becomes effective 90 days after
the Form 15 is filed
All IMO
Thanks for sharing.
The palintiffs did not present any new evidence for the reconsideration, so I don't believe that the court will take so long to make a decision. IMO.
To be fair, they talk about millions in billings, Not billions in sales.
A third way to become PK current information and remove CE label is to file un-audited fins and attorney's letter with OTC Markets
that's true on ihub, but otcmarkets still has the skull and crossbones and
Pink No Information
Dark or Defunct
Caveat Emptor
https://www.otcmarkets.com/stock/ARYC/overview
As I have pointed out before Form 15 can be used for terminating registration in that case, the form 10 route you mention makes sense.
Form 15 can also be used to suspend reporting without terminating registration. That is the way that Arrrayit filed the form by checking that box. But one of the requirements is that the company has to be current to qualify for that option, so we'll see if the SEC goes along with it..
Theranos and EverlyWell are private companies. Arrayit is a public company.
ARYC management makes decision without a shareholders vote because management has huge majority voting power from the many preferred shares they own and the votes of a few other family member and insiders. So we never get to vote on anything.
You ask:
Exactly. Rene ran the company as a private company for 15 years before it became public in 2009. She prefers to run it like a private company still. She never made the transition. She needs to be gone.
What did they say about the ex parte
Thanks in part to people attacking RRBB on their FB page
How many more shares until Nielsen is done selling ?
Today's hearing is only for Iconic's motion to lift the restrictions to trade the 72M ARYC shares.
You wish.
The good news is that the Arrayit allergy test is an LDT test that does NOT have to be FDA approved to be sold. That is true as long as Arrayit is the one that processes the test. LDT are tests created and processed by the same lab.
LDT = A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
The pinnertest lawsuit was filed on 4/4/19, after the April 1 fins debacle. So no this case had no bearing on the delay of the fins. The Taub and Iconic case may have, but we don't know for sure.
Also, it is true that Pinner USA is the company that sells pinnertest and created pinnertest website.
TravO, Sloan provided you the link. Thanks Sloan.
By the way, Pacer is for Federal cases, that's why you don't see it there . Iconic case in in San Diego Superior Court
Iconic ex-parte hearing Tuesday 9/24 @ 8:30 am PST
Arrayit filed documents on Monday 9/23. I haven't bought them. Did anyone buy them?
The IgE allergy test is where the money is, and it is scientifically accepted. In addition Arrayit has the only multiplex test, testing many allergens at one time, being sold in the U.S. Also it's covered by Medicare and private insurance.
pinnertest IgG test is just a side business